# US 2012/0253029 A1 · Process for the preparation of highly o-sulfated epimerized derivatives of k5 polysaccharide and intermediates therein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253029 A1
- Document ID: US20120253029A1
- Status: Published application
- Kind: A1
- Application number: 13/465,495
- Filed: 2012-05-07
- Published: 2012-10-04
- Earliest claimed: 2002-06-18
- Inventors: Pasqua Anna ORESTE; Giorgio Zoppetti
- Web page: https://patentgrep.com/patent/US20120253029A1

## CPC

- C08B 37/0006: {Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid}
- A61K 31/726: Glycosaminoglycans, i.e. mucopolysaccharides (chondroitin sulfate, dermatan sulfate A61K31/737)
- A61K 31/727: Heparin; Heparan
- A61K 31/737: Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (A61K31/727 takes precedence)
- C08B 37/006: {Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof}
- C08B 37/0075: {Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof}
- C08B 37/0078: {Degradation products}
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A new method is described for the oversulfation of epiK5-N-sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which, by subsequent N-sulfation, provides new epiK5-N,O-oversulfate-derivatives with a sulfation degree of at least 4, basically free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field. Also described are new low molecular weight epiK5-N-sulfates useful as intermediates in the preparation of the corresponding LMW-epiK5-N,O-oversulfate-derivatives.

## Claims

### Claim 1

A process for the preparation of epiK5-amine-O-oversulfate-derivatives having a glucosamine 3-O-sulfate content of at least 40%, which comprises
(a) treating an epiK5-N-sulfate-derivative, in acidic form, with a tertiary or quaternary organic base, letting the reaction mixture to stand for a time period of 30-60 minutes at a pH of approximately 7 and isolating the corresponding organic base salt of said epiK5-N-sulfate; and
(b) treating said tertiary amine or quaternary ammonium salt of said epiK5-N-sulfate-derivative with an O-sulfation agent in the conditions of O-oversulfation and isolating the epiK5-amine-O-oversulfate-derivative.

### Claim 2 (depends on 1)

The process of claim 1, wherein said epiK5-amine-O-oversulfate-derivative is isolated in form of sodium salt and optionally converted into another chemically or pharmaceutically acceptable salt.

### Claim 3 (depends on 1)

The process of claim 1, wherein said other chemically or pharmaceutically acceptable salt is a member selected from the group consisting of alkaline-earth metals, ammonium, tetra(C1-C4)alkylammonium, aluminum and zinc salts.

### Claim 4 (depends on 1)

The process of claim 1, wherein an epiK5-N-sulfate-derivative having a mean molecular weight from approximately 1,000 to approximately 25,000 is used as starting material.

### Claim 5 (depends on 4)

The process of claim 4, wherein said starting epiK5-N-sulfate-derivative has a mean molecular weight from approximately 1,000 to approximately 12,000.

### Claim 6 (depends on 4)

The process of claim 4, wherein said starting epiK5-N-sulfate-derivative has a mean molecular weight from approximately 1,500 to approximately 25,000.

### Claim 7 (depends on 6)

The process of claim 6, wherein said epiK5-N-sulfate-derivative has a mean molecular weight from approximately 10,000 to approximately 25,000.

### Claim 8 (depends on 1)

The process of claim 1, wherein said epiK5-N-sulfate-derivative is a LMW-epiK5-N-sulfate having a content in iduronic acid of from 40% to 60% and a mean molecular weight from approximately 1,500 to approximately 12,000.

### Claim 9 (depends on 8)

The process of claim 8, wherein said LMW-epiK5-N-sulfate has a mean molecular weight of from approximately 1,500 to approximately 10,000.

### Claim 10 (depends on 9)

The process of claim 9, wherein said LMW-epiK5-N-sulfate has a mean molecular weight of from approximately 1,500 to approximately 7,500.

### Claim 11 (depends on 1)

The process of claim 1, wherein an epiK5-N-sulfate-derivative consisting of a mixture of chains in which at least 90% of said chains have the formula I
in which 20-60% of the uronic units are those of iduronic acid, n is an integer from 2 to 100 and the corresponding cation is chemically or pharmaceutically acceptable, is used as starting material.

### Claim 12 (depends on 11)

The process of claim 11 wherein said starting material consists of a mixture of chains in which at least 90% of said chains have the formula I, in which 40-60% of the uronic units are those of iduronic acid.

### Claim 13 (depends on 12)

The process of claim 12 wherein, in formula I, n is an integer from 3 to 100.

### Claim 14

A LMW-epiK5-N-sulfate free of NH2 and acetyl groups having a content in iduronic acid of from 20% to 60% and a mean molecular weight of from approximately 1,000 to approximately 12,000.

### Claim 15 (depends on 14)

The LMW-epiK5-N-sulfate of claim 14 having a content in iduronic acid of from 40% to 60% and a molecular weight of from approximately 1,500 to approximately 10,000.

### Claim 16 (depends on 15)

The LMW-epiK5-N-sulfate of claim 15 having a mean molecular weight of from approximately 1,500 to approximately 7,500.
